Optic neuromyelitis. Main differences with multiple sclerosis;Neuromielitis óptica. Principales diferencias con la esclerosis múltiPle

Anales de Medicina Interna

Volumn 25, Issue 6, 2008, Pages 294-296

  Cabezas, I Lopategui ^a,d   Llano, M Cervantes ^b   Rol, G Pentón ^c  

^a INSTITUTO DE CIENCIAS BÁSICAS Y PRECLÍNICAS VICTORIA DE GIRÓN   (Cuba)

^b Ciencias Farmacéuticas   (Cuba)

^c CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^d NONE   (Cuba)

Author keywords

Autoim munity; Devic; Multiple sclerosis; Optic neuromyelitis

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; BETA1A INTERFERON; GLATIRAMER; IMMUNOGLOBULIN; INTERFERON BETA SERINE; NATALIZUMAB; PREDNISONE;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLINDNESS; INFLAMMATORY DISEASE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; OPTIC NEURITIS; REVIEW;

ACUTE DISEASE; ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANTIBODIES, MONOCLONAL; AUTOIMMUNITY; AZATHIOPRINE; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTENSIVE CARE UNITS; INTERFERON-BETA; MALE; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; PEPTIDES; PLASMAPHERESIS; PREVALENCE; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 64149131400     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Weinshenker B. Western vs Optic Spinal MS. Two diseases, one treatment ? Rev Neurol 2005; 64: 594-595.
2. De Seze. Borderlines types of Multiple Sclerosis. Rev Neurol 2006; 162: 137-43.
3. Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993; 34: 162-8.
4. Rocca MA, Acosta F, Mezzapesa DM, Martinelli V, Salvi F, Ghezzi A, et al. Magnetization transfer and diffusion tensor MRI show gray matter damage in Neuromyelitis Optica. Neurol 2004; 62: 476-478.
5. Filippi M, Rocca MA, Moiola L, et al. MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica. Neurol 1999; 53: 1705-1710.
6. Bergamaschi R, Tonietti S, Franciotta D, Candeloro E, T avazzi E, Piccolo G, et al. Oligoclonal bands in Devic's neuromyelitis Optica and Multiple Sclerosis: Differences in repeated cerebrospinal fluid examinations. Mult Scler 2004; 10: 2-4.
7. Nakashima I, Fujihara K, Fujimori J, Narikawa K, Misu T, Itoyama Y. Absence of IgG1 response in the cerebrospinal fluid of relapsing neu- romyelitis optica. Neurology 2004; 62: 144-6.
8. Lennon VA, Weinshenker BG. Identification of a marker autoantibody of Neuromyelitis Optica. Neurol 2003; 60 (5 Suppl 1): A519.
9. Lindsey LW, Albers GW, Steinman L. Recurrent transverse myelitis, myasthenia gravis, and autoantibodies. Ann Neurol 1992; 32: 407- 9.
10. Santos MA, Lana MA, Lei MS, Varella de A. Avaliacao dos potenciais evocados auditivos do tronco encefalico na esclerose multipla / Auditory evoked potentials in multiple sclerosis. Arq Neuropsiquiatr 2003; 61(2B): 392-397.
11. Wingerchuk DM, Hogancamp W, O'Brien P. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-14.
12. O'Riordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF, and MRI findings Devic's neuromyelitis optica. J Neurol Neurosurg Psy- chiatr 1996; 60: 382-7.
13. El Otmani H, Rafai MA, Moutaouakil F, El Moutawakkil B, Boulaajaj F Z, Moudden M, et al. Devic's neuromyelitis optica in Morocco. A study of 9-cases. Rev Neurol 2005; 161: 1191-6.
14. Kira J. Multiple Sclerosis in the Japanese population. Lancet Neurol 2003; 2: 117-127.
15. Singhal BS. Multiple sclerosis-Indian experience. Annals of the Academy of Medicine, Singapore 1985; 14: 32- 6.
16. Cabrera-Gómez JA. Esclerosis Múltiple en el Caribe. Arraigada R, Nogales Gaete, editores. Santiago de Chile; 2002.
17. Yamasaki K, Horiuchi I, Minohara M, et al. HLA-DRB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 1999; 122: 1689-1696.
18. Jacob ANR, Das K, Boggild M. Exploring the realionship between relapsing mielitis, neuromyelitis optica and multiple sclerosis. J Neurol Neuros Psychiatr 2004; 75: 1225.
19. Katz JD, Romper AH. Progressive necrotic myelopathy: clinical course in 9 patients. Arch Neurol 2000; 57: 355-361.
20. Poppe AY, Lapierre Y, Melancon D, Lowden D, Wardell L, Fullerton LM, et al. Neuromyelitis optica with hypothalamic involvement. Mult Scler 2005; 11: 617-21.
21. Williamson PM. Neuromyelitis optica following infectious mononucle- osis. Proc Aust Assoc Neurol 1975; 12: 153-155.
22. Doutlik S, Sblova O, Kryl R, Novak M. Neuromyelitis optica as a parainfectious complication of varicella. Cesk Neurol Neurochir 1975; 38: 238- 242.
23. Blanche P, Díaz E, Gombert B, Sicard D, Rivoal O, Brezin A. Devic's neuromyelitis optica and HIV-1 infection. J Neurol Neurosurg Psychiatry 2000; 68: 795-796.
24. Hagiwara N, Toyoda K, Uwatoko T, Yasumori K, Ibayashi S, Okada Y. Successful high dose glucocorticoid treatment for subacute neuromyeli- tis optica with systemic lupus erythematosus. Intern Med 2005; 44: 998-1001.
25. Gibbs AN; Moroney J, Foley-Nolan D, O'Connell PG. Neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus: a case report. Rheumatology 2002; 41: 470-471.
26. Mochizuki A, Hayashi A, Hisahara S, Shoji S. Steroid- responsive Devic's variant in Sjogren's syndrome. Neurol 2000; 54: 1391-1392.
27. Harada T, Ohashi T, Harada C, et al. A case of bilateral optic neuropathy and recurrent transverse myelopathy associated with perinuclear and anti-neutrophil cytoplasmic antibodies (p-ANCA). J Neuroophthal- mol 1997; 17: 254-256.
28. Vernart JC, Cabre P, Smadja D, et al. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome (see comments). Neurol 1997; 48: 58-64.
29. Misu T, Fujihara K, Nakashima I, sato S, Itoyama Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 2005; 65: 1479-82.
30. Biliciler S, Uygucgil H, Saip S, Altintas A, Soysal T, Ozdemir SE, et al. Plasmapheresis in multiple sclerosis patients with different indications. Mult Scler 2001; 7 (Suppl 1): 64.
31. Itoyama Y, Saida T, Tashiro K, Sato T, Ohashi Y, Japan TI-bMSCRGi. Japanese multicenter, randomized, double-blind trial of interferon beta- 1b in relapsing-remitting multiple sclerosis: two year results. Ann Neurol 2000; 48: 487.
32. Dib WJ. Terapia y neuroprotección en la Esclerosis múltiple. Actas del III congreso de Neurociencias de Castilla y León, Valladolid, octubre 2004.
33. Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone anDíazathio- prine. Neurol 1998; 51: 1219-20.